123 related articles for article (PubMed ID: 7739018)
1. Immunoglobulin and non-immunoglobulin components of human milk inhibit Clostridium difficile toxin A-receptor binding.
Rolfe RD; Song W
J Med Microbiol; 1995 Jan; 42(1):10-9. PubMed ID: 7739018
[TBL] [Abstract][Full Text] [Related]
2. Binding of Clostridium difficile toxin A to human milk secretory component.
Dallas SD; Rolfe RD
J Med Microbiol; 1998 Oct; 47(10):879-88. PubMed ID: 9788811
[TBL] [Abstract][Full Text] [Related]
3. Diminished Clostridium difficile toxin A sensitivity in newborn rabbit ileum is associated with decreased toxin A receptor.
Eglow R; Pothoulakis C; Itzkowitz S; Israel EJ; O'Keane CJ; Gong D; Gao N; Xu YL; Walker WA; LaMont JT
J Clin Invest; 1992 Sep; 90(3):822-9. PubMed ID: 1325998
[TBL] [Abstract][Full Text] [Related]
4. Purification of a functional receptor for Clostridium difficile toxin A from intestinal brush border membranes of infant hamsters.
Rolfe RD; Song W
Clin Infect Dis; 1993 Jun; 16 Suppl 4():S219-27. PubMed ID: 8324123
[TBL] [Abstract][Full Text] [Related]
5. Saccharomyces boulardii protease inhibits the effects of Clostridium difficile toxins A and B in human colonic mucosa.
Castagliuolo I; Riegler MF; Valenick L; LaMont JT; Pothoulakis C
Infect Immun; 1999 Jan; 67(1):302-7. PubMed ID: 9864230
[TBL] [Abstract][Full Text] [Related]
6. Vaccination with parenteral toxoid B protects hamsters against lethal challenge with toxin A-negative, toxin B-positive clostridium difficile but does not prevent colonization.
Siddiqui F; O'Connor JR; Nagaro K; Cheknis A; Sambol SP; Vedantam G; Gerding DN; Johnson S
J Infect Dis; 2012 Jan; 205(1):128-33. PubMed ID: 22124129
[TBL] [Abstract][Full Text] [Related]
7. Human colonic aspirates containing immunoglobulin A antibody to Clostridium difficile toxin A inhibit toxin A-receptor binding.
Kelly CP; Pothoulakis C; Orellana J; LaMont JT
Gastroenterology; 1992 Jan; 102(1):35-40. PubMed ID: 1309359
[TBL] [Abstract][Full Text] [Related]
8. A novel fusion protein containing the receptor binding domains of C. difficile toxin A and toxin B elicits protective immunity against lethal toxin and spore challenge in preclinical efficacy models.
Tian JH; Fuhrmann SR; Kluepfel-Stahl S; Carman RJ; Ellingsworth L; Flyer DC
Vaccine; 2012 Jun; 30(28):4249-58. PubMed ID: 22537987
[TBL] [Abstract][Full Text] [Related]
9. Human monoclonal antibodies directed against toxins A and B prevent Clostridium difficile-induced mortality in hamsters.
Babcock GJ; Broering TJ; Hernandez HJ; Mandell RB; Donahue K; Boatright N; Stack AM; Lowy I; Graziano R; Molrine D; Ambrosino DM; Thomas WD
Infect Immun; 2006 Nov; 74(11):6339-47. PubMed ID: 16966409
[TBL] [Abstract][Full Text] [Related]
10. Purification and characterisation of intracellular toxin A of Clostridium difficile.
Meng XQ; Kamiya S; Yamakawa K; Ogura H; Nakamura S
J Med Microbiol; 1993 Jan; 38(1):69-73. PubMed ID: 8418298
[TBL] [Abstract][Full Text] [Related]
11. Binding of Escherichia coli heat-stable toxin and rise of guanylyl cyclase activity in the brush-border membranes of rabbit intestinal epithelial cells.
Bhattacharya J; Chakrabarti MK
J Diarrhoeal Dis Res; 1999 Mar; 17(1):28-33. PubMed ID: 10892494
[TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo neutralizing activity of human colostrum and milk against purified toxins A and B of Clostridium difficile.
Kim K; Pickering LK; DuPont HL; Sullivan N; Wilkins T
J Infect Dis; 1984 Jul; 150(1):57-62. PubMed ID: 6747345
[TBL] [Abstract][Full Text] [Related]
13. Bovine immunoglobulin concentrate-clostridium difficile retains C difficile toxin neutralising activity after passage through the human stomach and small intestine.
Warny M; Fatimi A; Bostwick EF; Laine DC; Lebel F; LaMont JT; Pothoulakis C; Kelly CP
Gut; 1999 Feb; 44(2):212-7. PubMed ID: 9895380
[TBL] [Abstract][Full Text] [Related]
14. A receptor decoy inhibits the enterotoxic effects of Clostridium difficile toxin A in rat ileum.
Castagliuolo I; LaMont JT; Qiu B; Nikulasson ST; Pothoulakis C
Gastroenterology; 1996 Aug; 111(2):433-8. PubMed ID: 8690209
[TBL] [Abstract][Full Text] [Related]
15. Binding kinetics of Clostridium difficile toxins A and B to intestinal brush border membranes from infant and adult hamsters.
Rolfe RD
Infect Immun; 1991 Apr; 59(4):1223-30. PubMed ID: 1900806
[TBL] [Abstract][Full Text] [Related]
16. Real-time multiplex polymerase chain reaction assay for rapid detection of Clostridium difficile toxin-encoding strains.
Houser BA; Hattel AL; Jayarao BM
Foodborne Pathog Dis; 2010 Jun; 7(6):719-26. PubMed ID: 20113206
[TBL] [Abstract][Full Text] [Related]
17. Comparison of wild type with recombinant Clostridium difficile toxin A.
Gerhard R; Burger S; Tatge H; Genth H; Just I; Hofmann F
Microb Pathog; 2005; 38(2-3):77-83. PubMed ID: 15748809
[TBL] [Abstract][Full Text] [Related]
18. Asymptomatic carriage of Clostridium difficile and serum levels of IgG antibody against toxin A.
Kyne L; Warny M; Qamar A; Kelly CP
N Engl J Med; 2000 Feb; 342(6):390-7. PubMed ID: 10666429
[TBL] [Abstract][Full Text] [Related]
19. Antigenicity of amino-acid sequences from Clostridium difficile toxin B.
Torres JF; Monath TP
J Med Microbiol; 1996 Jun; 44(6):464-74. PubMed ID: 8636964
[TBL] [Abstract][Full Text] [Related]
20. Rabbit sucrase-isomaltase contains a functional intestinal receptor for Clostridium difficile toxin A.
Pothoulakis C; Gilbert RJ; Cladaras C; Castagliuolo I; Semenza G; Hitti Y; Montcrief JS; Linevsky J; Kelly CP; Nikulasson S; Desai HP; Wilkins TD; LaMont JT
J Clin Invest; 1996 Aug; 98(3):641-9. PubMed ID: 8698855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
